ALNYLAM PHARMACEUTICALS, INC. (ALNY) /
The debt of ALNYLAM PHARMACEUTICALS, INC. over the past 10 years
Chart ALNYLAM PHARMACEUTICALS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2024, ALNYLAM PHARMACEUTICALS, INC. had liquid cash of $2.69B and total debt of $1.02B: net cash of $1.67B. It had more liquid cash than debt at all 8 year-ends shown. Total debt was highest at the end of fiscal 2024 ($1.02B) and lowest at the end of fiscal 2019 ($0). No net cash figure is on file for fiscal 2020 and 2025.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.91B* | — | — |
| 2024ended Dec 31, 2024 | $2.69B* | $1.02B | $1.67B |
| 2023ended Dec 31, 2023 | $2.44B* | $1.02B | $1.42B |
| 2022ended Dec 31, 2022 | $2.19B* | $1.02B | $1.18B |
| 2021ended Dec 31, 2021 | $2.44B* | $675.7M | $1.76B |
| 2020ended Dec 31, 2020 | $1.87B* | — | — |
| 2019ended Dec 31, 2019 | $1.54B* | $0 | $1.54B |
| 2018ended Dec 31, 2018 | $1.08B* | $30M | $1.05B |
| 2017ended Dec 31, 2017 | $1.69B* | $30M | $1.66B |
| 2016ended Dec 31, 2016 | $626.8M* | $150M | $476.8M |
Fiscal years as ALNYLAM PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ALNYLAM PHARMACEUTICALS, INC.
- The revenue of ALNYLAM PHARMACEUTICALS, INC.
- The profitability of ALNYLAM PHARMACEUTICALS, INC.
- The cash flow of ALNYLAM PHARMACEUTICALS, INC.
- All of ALNYLAM PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTRSNORTHERN TRUST CORP
- WTWWILLIS TOWERS WATSON PLC
- RJFRAYMOND JAMES FINANCIAL, INC.
- MLMMARTIN MARIETTA MATERIALS INC
- HPQHP INC.
Not investment advice. This page shows what ALNYLAM PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.